MedTrace Logo

Post-Cardiotomy Extra-Corporeal Life Support Study

NCT03857217 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2019-02-27

No results posted yet for this study

Summary

Extracorporeal life support is increasingly used after cardiac surgery. Despite improved technology, outcome still remains poor.

This retrospective multicenter cohort study aims to find the (risk) factors associated with the poor prognosis of these patients.

Adult patients who received ECLS after cardiac surgery between 2000 and 2018 are eligible for inclusion

Conditions

  • Cardiogenic Shock
  • Resuscitation
  • Cardiac Surgery

Interventions

DEVICE

Extra-Corporeal Membrane Oxygenation

ECMO is implanted in cardiac surgery patients.

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-31
Primary Completion
2019-08-31
Completion
2019-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03857217 on ClinicalTrials.gov